A detailed history of Aperture Investors, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Aperture Investors, LLC holds 74,585 shares of NTRA stock, worth $12.1 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares
74,585
Previous 87,673 14.93%
Holding current value
$12.1 Million
Previous $9.49 Million 0.16%
% of portfolio
1.44%
Previous 1.55%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$97.75 - $129.67 $1.28 Million - $1.7 Million
-13,088 Reduced 14.93%
74,585 $9.48 Million
Q2 2024

Aug 14, 2024

BUY
$85.28 - $112.6 $7.48 Million - $9.87 Million
87,673 New
87,673 $9.49 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Aperture Investors, LLC Portfolio

Follow Aperture Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aperture Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aperture Investors, LLC with notifications on news.